Andy Sassine bought $20k of ARCT
Chief Financial Officer at Arcturus Therapeutics Holdings Inc.. 1,238 shares at an average of $16.56, traded Aug 15, 2025, filed Aug 19, 2025.
Score components
- +22RoleCFO
- 0Trade size$20k at market
- -5Relative to holdingsUnder 1% of holdings (0.6%)
- +4Price context24% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193805-25-001212, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 15, 2025 | POpen-market purchase Common Stock | -1,238 | $16.56 | $20k | 221,764 | Aug 19, 2025 |
Related signals
Other insiders at Arcturus Therapeutics Holdings Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 21Weak | ARCTbuy Arcturus Therapeutics Holdings Inc. | Andy Sassine Chief Financial Officer | $20k 1,238 shares | +1% | |
| 13Weak | Arcturus Therapeutics Holdings Inc. | Pad Chivukula Chief Scientific Officer & COO | $249k 12,000 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.